Attana at PEGS 2010- the essential protein engineering summit

Tid 17 Maj 2010 – 21 Maj 2010

Plats Sheraton Boston Hotel, Boston Massachusetts

Staffan Grenklo Ph.D, Cell Biologist, Attana AB Presentation focus: In today’s quest for new therapeutic drugs, it is increasingly important to obtain early and informative data on potential agents in order to save time and costs. Combining biosensor technologies contributing to detailed information on molecular interactions with an experimental approach, as close as possible to the natural environment of action, increases the chances of selecting the optimal candidate already in the pre-clinical phase. Track: Pre-clinical/ clinical development of Antibodies, Wed May 19th http://www.pegsummit.com/

Kategorier

  • attana cell 200
  • attana
  • biosensor
  • biosensors
  • attana a200
  • qcm
  • pegs 2010

Kontakter

Teodor Aastrup

Chief Executive Officer Chief Executive Officer

Relaterat innehåll

Relaterade event